ACHE and early-onset autosomal dominant Alzheimer disease: Previous studies have demonstrated that berberine possesses multiple activities in Alzheimer's disease therapy, including antioxidant activity, AChE and BChE inhibitory activity, MAO inhibitory activity, and reducing Aβ level and lowering cholesterol [58].